| Net earnings | |
| Share-based compensation expense | 48.3M |
| Tax benefits from exercises of share-based payment awards | |
| Excess tax benefits from share-based compensation | |
| Depreciation | 64.2M |
| Amortization of intangible assets | 15.6M |
| Deferred taxes | -23.9M |
| Provision for doubtful accounts receivable | 3.5M |
| Net change in fair value of derivatives and underlying commitments | |
| Loss (gain) on equity investment in affiliate | |
| Other | 2.1M |
| Accounts receivable | -168.3M |
| Inventories | -27.7M |
| Prepaid expenses and other current assets | 8M |
| Accounts payable | 9.7M |
| Accrued expenses | |
| Deferred revenues | |
| Product warranty | |
| Advance payments from customers | |
| Other long-term liabilities | |
| Net cash provided by operating activities | 356.3M |
| Purchases of property, plant and equipment | -80.4M |
| Investment in a privately held company | |
| Acquisition of businesses, net of cash acquired | |
| Decrease in cash surrender value of life insurance | |
| Note repayment (receivable) from affiliate and other, net | |
| Other, net | 400K |
| Net cash used in investing activities | -109.2M |
| Repurchases of common stock | -461.3M |
| Equity forward contracts | |
| Proceeds from issuance of common stock to employees | 60.6M |
| Net borrowings (payments) under line of credit agreements | |
| Excess tax benefits from share-based compensation | 3.9M |
| Employees' taxes withheld and paid for restricted stock and restricted stock units | |
| Repayments of bank borrowings | |
| Other | 500K |
| Net cash used in financing activities | -245.8M |
| Effects of exchange rate changes on cash and cash equivalents | -3.3M |
| Net increase in cash and cash equivalents | -2M |
| Cash and cash equivalents at beginning of period | 845.5M |
| Cash and cash equivalents at end of period | 843.5M |
| Value of VMS stock received upon settlement of the February 2011 Repurchase Agreement | |